文献速递主动脉疾病

何时停止:优化老年腹主动脉瘤监测策略

When to stop: Optimizing abdominal aortic aneurysm surveillance in the elderly.
PubMed 文献 · J Vasc Surg · 2026-06-12

本研究基于多中心注册数据,纳入10,629例≥65岁无症状腹主动脉瘤患者,分析年龄、合并症和动脉瘤大小对进展至干预直径或死亡的影响。结果显示,≥85岁女性或≥80岁男性且动脉瘤<3.5 cm者,死亡先于进展的概率>90%,可考虑停止监测;合并症负担高者阈值更低。

要点

  • ≥85岁女性或≥80岁男性,动脉瘤<3.5 cm,死亡先于进展概率>90%,可停止监测。
  • 高合并症负担(80百分位)吸烟者,男性≥75岁且瘤径2.7-3.4 cm或≥85岁且瘤径<4 cm也可停止。
  • 结合年龄、瘤径和合并症可个体化制定监测方案。

核心结论

  • 对于≥85岁女性或≥80岁男性且动脉瘤<3.5 cm者,死亡先于进展的概率>90%,可停止监测。
  • 结合合并症负担、年龄和主动脉直径可制定个体化监测建议。

研究设计与样本

  • 多中心、综合健康系统动脉瘤注册数据,2007-2024年,纳入≥65岁患者10,629例,中位年龄74岁,80.3%男性。
  • 采用分位数回归和时间-事件分析,复合终点包括死亡、进展至干预直径(女性5 cm,男性5.5 cm)或AAA干预。

主要发现

  • 10年死亡率为62%。
  • 未调整分析中,女性瘤径2.7-3.4 cm者14.6%在死亡前达到可手术大小,3.5-4 cm者39.3%,4-4.5 cm者60%,4.5-5 cm者79%。
  • 男性瘤径2.7-3.4 cm者7.9%在死亡前达到可手术大小,3.5-4 cm者59.1%,4-4.5 cm者47.5%,>5 cm者73.6%。
  • 模型显示,≥85岁女性且瘤径<3.5 cm、≥80岁男性且瘤径<3.5 cm,死亡作为首次事件概率≥90%。
  • 高合并症负担(80百分位)吸烟者中,≥75岁男性且瘤径2.7-3.4 cm、≥85岁男性且瘤径<4 cm、≥85岁女性且瘤径2.7-3.4 cm,死亡先于进展概率≥90%。

关键数值与推荐

  • 监测停止阈值:死亡作为首次事件的概率>90%。
  • 干预直径:女性5 cm,男性5.5 cm。
  • 合并症采用内部验证的风险指数分层,分析中使用了20th和80th百分位合并症评分。

临床怎么用

  • 对≥85岁女性或≥80岁男性且动脉瘤<3.5 cm者,可考虑停止监测。
  • 对高合并症负担的吸烟者,可结合年龄和瘤径(如男性≥75岁且2.7-3.4 cm)更早停止监测。
  • 监测决策应结合年龄、动脉瘤大小和合并症负担进行个体化评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Many older adults with asymptomatic abdominal aortic aneurysms (AAAs) smaller than the recommended intervention diameter may not benefit from lifelong surveillance. This study aimed to identify subgroups with a low likelihood of AAA progression to the intervention diameter relative to death based on age, comorbidities, and aneurysm size. METHODS: We used the multicenter, aneurysm registry data of an integrated health system from 2007 to 2024. Patients aged 65 years or older were included, and comorbidities were stratified using an internally validated risk index. The AAA size at the first scan was determined through ultrasound or cross-sectional imaging. Quantile regression with time-to-event analysis was utilized. The composite event included death, progression to the intervention size (5 cm in women, 5.5 cm in men), or AAA intervention. Both the time to the first event and the probability that the first event was death, rather than aneurysm progression, were determined across ages and aneurysm sizes for those with a median comorbidity score. A >90% probability of death as the first event was the cutoff for surveillance cessation. This analysis was replicated for hypertensive smokers or never smokers at the 20th and 80th percentile comorbidity scores. RESULTS: A total of 10,629 patients meeting the inclusion criteria were identified. The median age was 74 years; 80.3% were male. The median starting aneurysm size for both genders was 3.5 cm. The 10-year mortality rate was 62%. In unadjusted analyses, among women, the following percentages of AAA of certain sizes reached operable size before death: 14.6% of aneurysms with sizes of 2.7 to 3.4 cm, 39.3% with sizes of 3.5 to 4 cm, 60% with sizes of 4 to 4.5 cm, and 79% with sizes of 4.5 to 5 cm. For men, the percentages were as follows: 7.9% of aneurysms with sizes of 2.7 to 3.4 cm, 59.1% with sizes of 3.5 to 4 cm, 47.5% with sizes of 4 to 4.5 cm, and 73.6% with sizes of >5 cm. In the model, women older than 85 years with aneurysms smaller than 3.5 cm had a ≥90% probability that their first event was death and not progression to the intervention threshold; this was true for men aged >80 years with aneurysms smaller than 3.5 cm. In patients with higher comorbidity burdens (80th percentile comorbidity score, current or former smokers), there was a ≥90% probability of death before reaching the operative size for men aged 75 years and older with AAA sizes of 2.7 to 3.4 cm, men aged 85 years or older with AAA sizes of <4 cm, and women aged 85 years or older with AAA sizes of 2.7 to 3.4 cm. CONCLUSIONS: Surveillance can cease for women aged 85 years or older or men aged 80 years or older with aneurysms smaller than 3.5 cm because the probability of death before aneurysm progression is >90%. Factoring in comorbidity burdens in addition to age and aortic diameter facilitates patient-specific recommendations to optimize surveillance.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Mangipudi S, Flanagan CP, Wong-On-Wing A, et al. When to stop: Optimizing abdominal aortic aneurysm surveillance in the elderly. J Vasc Surg. 2026. PMID: 42285179. doi:10.1016/j.jvs.2026.05.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。